Article Information
PubMed
Print ISSN
Online ISSN
History
- Received April 2, 2020
- Accepted October 21, 2020
- Published online December 23, 2020.
Article Versions
- Earlier version (November 2, 2020 - 01:22).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2020 by The American Society for Pharmacology and Experimental Therapeutic
Author Information
- Simon G. Wong1,
- Diane Ramsden2,
- Shannon Dallas,
- Conrad Fung,
- Heidi J. Einolf,
- Jairam Palamanda3,
- Liangfu Chen,
- Theunis C. Goosen,
- Y. Amy Siu4,
- George Zhang,
- Donald Tweedie,
- Niresh Hariparsad5,
- Barry Jones6, and
- Phillip D. Yates7
- Genentech, South San Francisco, California (S.G.W.); Alnylam Pharmaceuticals, Cambridge, Massachusetts (D.R.); Janssen R&D, Spring House, Pennsylvania (S.D.); Vertex Pharmaceuticals, Boston, Massachusetts (C.F., N.H.); Novartis, East Hanover, New Jersey (H.J.E.); GlaxoSmithKline, King of Prussia, Pennsylvania (L.C.); Pfizer Global Research and Development, Groton, Connecticut (T.C.G.); Pfizer Global Research and Development, Cambridge, Massachusetts (P.D.Y.); Eisai, Cambridge, Massachusetts (Y.A.S.); Corning Life Sciences, Woburn, Massachusetts (G.Z.); Merck & Co., Inc., Kenilworth, New Jersey (D.T., J.P.); and AstraZeneca, Cambridge, Cambridgeshire, United Kingdom (B.J.)
- Address correspondence to:
Niresh Hariparsad, AstraZeneca, 35 Gatehouse Dr., Waltham, MA 02451. E-mail: Niresh.hariparsad{at}astrazeneca.com